SC
JAZZ icon

SouthState Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

SouthState Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.59K Hold
19
– – ﹤0.01% 806
2025
Q4 		$3.23K Sell
19
-14
-42% -$2.15K ﹤0.01% 889
2025
Q3 		$4.35K Sell
33
-104
-76% -$12.5K ﹤0.01% 782
2025
Q2 		$14.5K Buy
137
+100
+270% +$10.9K ﹤0.01% 712
2025
Q1 		$4.59K Buy
+37
New +$4.83K ﹤0.01% 1008

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SouthState Corp's JAZZ Position: Q1 2026 in Review

SouthState Corp held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 19 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

SouthState Corp first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. The position peaked at $14.5K in Q2 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • SouthState Corp held 19 shares of Jazz Pharmaceuticals worth $3.59K as of Q1 2026.
  • SouthState Corp left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #806 holding.
  • SouthState Corp first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • SouthState Corp's Jazz Pharmaceuticals position peaked at $14.5K in Q2 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.